Skip to main content

Peer Review reports

From: Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial

Original Submission
13 Jan 2020 Submitted Original manuscript
9 Mar 2020 Author responded Author comments - Nut Koonrungsesomboon
Resubmission - Version 2
9 Mar 2020 Submitted Manuscript version 2
Publishing
12 Mar 2020 Editorially accepted
30 Mar 2020 Article published 10.1186/s12885-020-06751-2

You can find further information about peer review here.

Back to article page
\